Skip Navigation



JAC Advance Access published online on July 1, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg308
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/2/176    most recent
dkg308v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Tsuchiya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Tsuchiya, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Brief report

An RND-type multidrug efflux pump SdeXY from Serratia marcescens

Jing Chen 1 , Teruo Kuroda 1 , Md Nazmul Huda 1 , Tohru Mizushima 1 , and Tomofusa Tsuchiya 1 *

1 Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama 700-8530, Japan

* Corresponding author. E-mail: tsuchiya{at}pharm.okayama-u.ac.jp.

Received 18 March 2003 ; revised 28 April 2003 ; accepted 29 April 2003

Abstract

Objectives: Serratia marcescens, an important cause of nosocomial infections, shows intrinsic resistance to a wide variety of antimicrobial agents (multidrug resistance). Multidrug efflux pumps are often involved in the multidrug resistance in many bacteria. A study was undertaken to characterize the multidrug efflux pumps in S. marcescens.

Methods: The genes responsible for the multidrug resistance phenotype in S. marcescens were cloned into Escherichia coli KAM32, a drug-hypersusceptible strain, for further analysis.

Results: We cloned sdeXY genes and determined the nucleotide sequence. Clones that carried the sdeXY genes displayed reduced susceptibility to several antimicrobial agents including erythromycin, tetracycline, norfloxacin, benzalkonium chloride, ethidium bromide, acriflavine and rhodamine 6G. A protein similarity search using GenBank revealed that SdeY is a member of the resistance nodulation cell-division (RND) family of multidrug efflux proteins and SdeX is a member of the membrane fusion proteins. Introduction of sdeXY into E. coli cells possessing tolC, but not in cells lacking tolC, resulted in multidrug resistance. We observed energy-dependent ethidium efflux in cells of E. coli KAM32 possessing sdeXY and tolC.

Conclusions: SdeXY is the first RND-type multidrug efflux pump to be characterized in multidrug-resistant S. marcescens.

Keywords: SdeXY, multidrug efflux pump, RND family, S. marcescens
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Bacteriol.Home page
S. K. Aoki, J. S. Webb, B. A. Braaten, and D. A. Low
Contact-Dependent Growth Inhibition Causes Reversible Metabolic Downregulation in Escherichia coli
J. Bacteriol., March 15, 2009; 191(6): 1777 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
S. Begic and E. A. Worobec
The role of the Serratia marcescens SdeAB multidrug efflux pump and TolC homologue in fluoroquinolone resistance studied via gene-knockout mutagenesis
Microbiology, February 1, 2008; 154(2): 454 - 461.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
T. Matsuo, J. Chen, Y. Minato, W. Ogawa, T. Mizushima, T. Kuroda, and T. Tsuchiya
SmdAB, a Heterodimeric ABC-Type Multidrug Efflux Pump, in Serratia marcescens
J. Bacteriol., January 15, 2008; 190(2): 648 - 654.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
T. Matsuo, K. Hayashi, Y. Morita, M. Koterasawa, W. Ogawa, T. Mizushima, T. Tsuchiya, and T. Kuroda
VmeAB, an RND-type multidrug efflux transporter in Vibrio parahaemolyticus
Microbiology, December 1, 2007; 153(12): 4129 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Schumacher, P. Steinke, J. A. Bohnert, M. Akova, D. Jonas, and W. V. Kern
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli
J. Antimicrob. Chemother., February 1, 2006; 57(2): 344 - 348.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Poole
Efflux-mediated antimicrobial resistance
J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Kumar and E. A. Worobec
Cloning, Sequencing, and Characterization of the SdeAB Multidrug Efflux Pump of Serratia marcescens
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1495 - 1501.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.